Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial
Cholesterol homeostasis, defined as the balance between absorption and synthesis, influences circulating cholesterol concentrations and subsequent coronary heart disease (CHD) risk. Statin therapy targets the rate-limiting enzyme in cholesterol biosynthesis and is efficacious in lowering CHD events...
Main Authors: | Nirupa R. Matthan, Nancy Resteghini, Michele Robertson, Ian Ford, James Shepherd, Chris Packard, Brendan M. Buckley, J. Wouter Jukema, Alice H. Lichtenstein, Ernst J. Schaefer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-01-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520313900 |
Similar Items
-
Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
by: Nirupa R. Matthan, et al.
Published: (2009-09-01) -
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL
by: Nirupa R. Matthan, et al.
Published: (2003-04-01) -
Biosynthesis of squalene and sterols by rat aorta
by: MARIE M. DALY
Published: (1971-05-01) -
Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity
by: Helena Gylling, et al.
Published: (2004-09-01) -
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers*[S]
by: Thomas M. van Himbergen, et al.
Published: (2009-04-01)